These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4009599)

  • 1. Thiol-containing androgens as suicide substrates of aromatase.
    Bednarski PJ; Porubek DJ; Nelson SD
    J Med Chem; 1985 Jun; 28(6):775-9. PubMed ID: 4009599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of thiol-containing androgens with human placental aromatase.
    Bednarski PJ; Nelson SD
    J Med Chem; 1989 Jan; 32(1):203-13. PubMed ID: 2909733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive inhibition and suicide inactivation of human placental aromatase by androst-4-ene-3,6-dione derivatives and 3 alpha-methoxyandrost-4-ene-6,17-dione.
    Numazawa M; Mutsumi A; Kigawa H
    Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3076-80. PubMed ID: 2085891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of 19-aza- and 19-aminoandrostenedione analogues as potential aromatase inhibitors.
    Lovett JA; Darby MV; Counsell RE
    J Med Chem; 1984 Jun; 27(6):734-40. PubMed ID: 6547488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androst-5-ene-7,17-dione: a novel class of suicide substrate of aromatase.
    Numazawa M; Mutsumi A; Hoshi K; Tanaka Y
    Biochem Biophys Res Commun; 1992 Jul; 186(1):32-9. PubMed ID: 1632774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical studies of estr-4-ene-3,6,17-trione and 5 alpha-androstan-17-ones with or without a carbonyl function at C-3 and/or C-6 as aromatase inhibitors.
    Numazawa M; Mutsumi A; Tachibana M; Nagaoka M
    Biol Pharm Bull; 1995 Apr; 18(4):555-8. PubMed ID: 7655426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of a new series of mechanism-based aromatase inhibitors.
    Lesuisse D; Gourvest JF; Hartmann C; Tric B; Benslimane O; Philibert D; Vevert JP
    J Med Chem; 1992 May; 35(9):1588-97. PubMed ID: 1578485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism for aromatase inactivation by a suicide substrate, androst-4-ene-3,6,17-trione. The 4 beta, 5 beta-epoxy-19-oxo derivative as a reactive electrophile irreversibly binding to the active site.
    Numazawa M; Mutsumi A; Tachibana M
    Biochem Pharmacol; 1996 Oct; 52(8):1253-9. PubMed ID: 8937433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies directed toward a mechanistic evaluation of aromatase inhibition by androst-5-ene-7,17-dione. Time-dependent inactivation by the 19-nor and 5 beta, 6 beta-epoxy derivatives.
    Numazawa M; Tachibana M
    Steroids; 1997 Jul; 62(7):516-22. PubMed ID: 9253790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition and inactivation of estrogen synthetase (aromatase) by fluorinated substrate analogues.
    Marcotte PA; Robinson CH
    Biochemistry; 1982 May; 21(11):2773-8. PubMed ID: 7093221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3 beta-hydroxyandrost-4-en-6-one derivatives as aromatase inhibitors.
    Numazawa M; Mutsumi A; Tsuji M
    Steroids; 1989 Sep; 54(3):299-311. PubMed ID: 2588304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 10 beta-propynyl-substituted steroids. Mechanism-based enzyme-activated irreversible inhibitors of estrogen biosynthesis.
    Covey DF; Hood WF; Parikh VD
    J Biol Chem; 1981 Feb; 256(3):1076-9. PubMed ID: 7451489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymic aromatization of 6-alkyl-substituted androgens, potent competitive and mechanism-based inhibitors of aromatase.
    Numazawa M; Yoshimura A; Oshibe M
    Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):151-6. PubMed ID: 9405288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of 19-hydroxy- 19-oxo-, and aromatizing-activities in human placental microsomes through the use of suicide substrates to aromatase.
    Bednarski PJ; Nelson SD
    J Steroid Biochem; 1989 Feb; 32(2):309-16. PubMed ID: 2921872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroperoxides as inactivators of aromatase: 10 beta-hydroperoxy-4-estrene-3,17-dione, crystal structure and inactivation characteristics.
    Covey DF; Hood WF; Beusen DD; Carrell HL
    Biochemistry; 1984 Nov; 23(23):5398-406. PubMed ID: 6509027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 19-(cyclopropylamino)-androst-4-en-3,17-dione: a mechanism-based inhibitor of aromatase.
    Njar VC; Düerkop J; Hartmann RW
    J Enzyme Inhib; 1996; 10(1):47-56. PubMed ID: 8835929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biochemical studies of 16- or 19-substituted androst-4-enes as aromatase inhibitors.
    Numazawa M; Mutsumi A; Hoshi K; Oshibe M; Ishikawa E; Kigawa H
    J Med Chem; 1991 Aug; 34(8):2496-504. PubMed ID: 1875347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tritium release from [19-3H]-19,19-difluoroandrost-4-ene-3,17-dione during inactivation of aromatase.
    Furth PS; Robinson CH
    Biochemistry; 1989 Feb; 28(3):1254-9. PubMed ID: 2653438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-dependent aromatase inactivation by 4 beta,5 beta-epoxides of the natural substrate androstenedione and its 19-oxygenated analogs.
    Numazawa M; Yoshimura A; Tachibana M; Shelangouski M; Ishikawa M
    Steroids; 2002 Mar; 67(3-4):185-93. PubMed ID: 11856542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of human placental aromatase by 6 alpha- and 6 beta-hydroperoxyandrostenedione.
    Tan L; Petit A
    Biochem Biophys Res Commun; 1985 Apr; 128(2):613-20. PubMed ID: 3994715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.